share_log

Wells Fargo Maintains Equal-Weight on Ventyx Biosciences, Lowers Price Target to $3

Benzinga ·  Dec 19, 2023 08:30

Wells Fargo analyst Derek Archila maintains Ventyx Biosciences (NASDAQ:VTYX) with a Equal-Weight and lowers the price target from $8 to $3.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment